These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Consumption costs and earnings during added years of life - a reply to Nyman. Gandjour A Health Econ; 2006 Mar; 15(3):315-7; discussion 319-22. PubMed ID: 16444762 [No Abstract] [Full Text] [Related]
5. Money matters: what to look for in an economic analysis. Dijksman LM; Poolman RW; Bhandari M; Goeree R; Tarride JE; Acta Orthop; 2008 Feb; 79(1):1-11. PubMed ID: 18283565 [No Abstract] [Full Text] [Related]
6. Cost-inclusive evaluation: a banquet of approaches for including costs, benefits, and cost-effectiveness and cost-benefit analyses in your next evaluation. Yates BT Eval Program Plann; 2009 Feb; 32(1):52-4. PubMed ID: 18977532 [TBL] [Abstract][Full Text] [Related]
7. The costs and benefits of enhanced depression care to employers. Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009 [TBL] [Abstract][Full Text] [Related]
8. A guide to economic evaluation: methods for cost-effectiveness analysis of person-level data. Hoch JS; Smith MW J Trauma Stress; 2006 Dec; 19(6):787-97. PubMed ID: 17195977 [TBL] [Abstract][Full Text] [Related]
9. On the lottery equivalents method: a response to Spencer et al. Oliver A Health Econ; 2006 Mar; 15(3):323-5. PubMed ID: 16432804 [No Abstract] [Full Text] [Related]
10. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes. Hoerger TJ Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014 [TBL] [Abstract][Full Text] [Related]
11. [Health economy assessments--how to find them]. Alton V; Eckerlund I; Norlund A Lakartidningen; 2006 May 31-Jun 6; 103(21-22):1726-33. PubMed ID: 16826717 [No Abstract] [Full Text] [Related]
12. Cost-effectiveness of captopril therapy after myocardial infarction. Tsevat J; Duke D; Goldman L; Pfeffer MA; Lamas GA; Soukup JR; Kuntz KM; Lee TH J Am Coll Cardiol; 1995 Oct; 26(4):914-9. PubMed ID: 7560617 [TBL] [Abstract][Full Text] [Related]
13. Pharmacoeconomic concepts in antiplatelet therapy: understanding cost-effectiveness analyses using clopidogrel as an example. Weintraub WS J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):107-19. PubMed ID: 18495905 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of screening for abdominal aortic aneurysm in the Netherlands and Norway. Spronk S; van Kempen BJ; Boll AP; Jørgensen JJ; Hunink MG; Kristiansen IS Br J Surg; 2011 Nov; 98(11):1546-55. PubMed ID: 21725968 [TBL] [Abstract][Full Text] [Related]
15. How do we evaluate the economics of health care? Kumar S; Williams AC; Sandy JR Eur J Orthod; 2006 Dec; 28(6):513-9. PubMed ID: 17035484 [TBL] [Abstract][Full Text] [Related]
16. Costing and perspective in published cost-effectiveness analysis. Neumann PJ Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023 [TBL] [Abstract][Full Text] [Related]
17. [Methods for cost-effectiveness evaluation of intensive care]. Heslet L; Andersen JS; Keiding H Ugeskr Laeger; 2007 Feb; 169(8):721-4. PubMed ID: 17313927 [TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness of hip fracture in Japan]. Ota T; Harada A; Tokuda H Nihon Ronen Igakkai Zasshi; 2002 Sep; 39(5):483-8. PubMed ID: 12404738 [No Abstract] [Full Text] [Related]